首页> 外文期刊>Neuropathology: official journal of the Japanese Society of Neuropathology >Diffuse midline gliomas with histone H3‐K27M mutation: A rare case with PNET‐like appearance and neuropil‐like islands
【24h】

Diffuse midline gliomas with histone H3‐K27M mutation: A rare case with PNET‐like appearance and neuropil‐like islands

机译:与组蛋白H3-K27M突变的弥漫中线胶质瘤:一种罕见的外观和神经潜像岛的罕见情况

获取原文
获取原文并翻译 | 示例
       

摘要

Diffuse midline glioma with histone H3‐K27M mutation is a new tumor entity defined by the 2016 WHO Classification of Tumors of the Central Nervous System. A 51‐year‐old Chinese woman presented with neck pain for a month. Subsequent MRI revealed an intramedullary neoplasm extending from C5 to C7. Histologically, the cellular area of the tumor was composed of primitive, poorly differentiated, small cells with scant cytoplasm, nuclear molding, and brisk mitotic activity, exhibiting PNET‐like appearance, while in the hypocellular area, oligodendroglioma‐like cells were observed. More importantly, neuropil‐like islands were observed in the cellular area. Microvascular proliferation was noted, with no necrosis. Besides histone H3K27M mutation, immunohistochemical staining also showed that the tumor cells were positive for oligodendrocyte lineage transcription factor 2 and ATRX. The neuropil‐like areas were positive for synaptophysin, intermingled with scattered neuronal nuclear antigen positive cells. The Ki‐67 proliferation index was about 30%, and tumor cells were highly immunopositive for p53. Sequencing for IDH1 codon 132 and IDH2 codon 172 gene mutations showed negative results. Furthermore, fluorescent analysis revealed 1p deletion in the lesion but no 19q deletion. Based on these findings, the tumor was diagnosed as diffuse midline gliomas with histone H3‐K27M mutation in the spinal cord, corresponding to WHO grade IV. After 4?months of remission, the tumor recurred; 2?months later, the patient died. Herein, we report an extremely rare case of diffuse midline glioma with histone H3K27M mutation, which was morphologically characterized simultaneously by primitive neuroectodermal tumor‐like appearance and neuropil‐like islands.
机译:弥漫性中线胶质瘤与组蛋白H3-K27M突变是由2016年定义的新肿瘤实体,世卫组织的肿瘤分类中枢神经系统的分类。一个51岁的中国女子患有一个月的颈部疼痛。随后的MRI揭示了从C5至C7延伸的髓内肿瘤。组织学上,肿瘤的细胞面积由原始,分化的小细胞组成,小细胞,具有瘢痕细胞质,核模塑和短暂的有丝分裂活性,表现出pnet的外观,而在下细胞面积中,观察到少突胶质瘤样细胞。更重要的是,在细胞面积中观察到神经覆盖岛的岛屿。注意到微血管增殖,没有坏死。除了组蛋白H3K27M突变之外,免疫组织化学染色还表明肿瘤细胞对于少突细胞谱系转录因子2和ATRX是阳性的。神经覆盖物的区域对于突触蛋白呈阳性,用散射的神经元核抗原阳性细胞混合。 KI-67增殖指数约为30%,肿瘤细胞对于P53具有高度免疫阳性。 IDH1密码子132和IDH2密码子172基因突变的测序显示出阴性结果。此外,荧光分析显示出病变中的1P缺失,但第19季度缺失。基于这些发现,肿瘤被诊断为在脊髓中具有组蛋白H3-K27M突变的弥漫性中线胶质瘤,对应于世卫组织级。在4个月后的缓解后,肿瘤重复; 2?几个月后,病人死了。在此,我们报告了具有组蛋白H3K27M突变的极其罕见的中线胶质瘤,其通过原始神经分区肿瘤的外观和神经皮岛的神经聚心瘤类似的形态表征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号